BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16764960)

  • 1. Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability.
    Dass CR; Choong PF
    J Control Release; 2006 Jun; 113(2):155-63. PubMed ID: 16764960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: lessons from gene therapy.
    Dass CR; Choong PF
    Cancer Cell Int; 2006 Jun; 6():17. PubMed ID: 16792817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises.
    Karmali PP; Chaudhuri A
    Med Res Rev; 2007 Sep; 27(5):696-722. PubMed ID: 17022036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic liposomes for gene delivery.
    Simões S; Filipe A; Faneca H; Mano M; Penacho N; Düzgünes N; de Lima MP
    Expert Opin Drug Deliv; 2005 Mar; 2(2):237-54. PubMed ID: 16296751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide delivery to tumours using macromolecular carriers.
    Dass CR
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles.
    Suzuki R; Takizawa T; Negishi Y; Utoguchi N; Sawamura K; Tanaka K; Namai E; Oda Y; Matsumura Y; Maruyama K
    J Control Release; 2008 Jan; 125(2):137-44. PubMed ID: 18035442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of novel cationic liposomes utilized for cancer gene therapy.
    Serikawa T; Kikuchi A; Sugaya S; Suzuki N; Kikuchi H; Tanaka K
    J Control Release; 2006 Jul; 113(3):255-60. PubMed ID: 16793160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted gene therapy of LS174 T human colon carcinoma by anti-TAG-72 immunoliposomes.
    Kim KS; Lee YK; Kim JS; Koo KH; Hong HJ; Park YS
    Cancer Gene Ther; 2008 May; 15(5):331-40. PubMed ID: 18309354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.
    Li SD; Huang L
    Gene Ther; 2006 Sep; 13(18):1313-9. PubMed ID: 16953249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of bacteria in anti-cancer therapies.
    Ryan RM; Green J; Lewis CE
    Bioessays; 2006 Jan; 28(1):84-94. PubMed ID: 16369949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
    Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
    Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of fucosylated cationic liposome/NFkappaB decoy complexes in the treatment of cytokine-related liver disease.
    Higuchi Y; Kawakami S; Yamashita F; Hashida M
    Biomaterials; 2007 Jan; 28(3):532-9. PubMed ID: 16982089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy of critical ischemia of the legs. Improvement of genetic transfection efficiency of endothelial cells in vitro, using cationic liposomes and protamine sulfate].
    Costantini V; Allegrucci M; Paolucci MC; Ricci M; Stabile AM; Presilla MC; Nenci GG
    Minerva Cardioangiol; 1999 Dec; 47(12):662-3. PubMed ID: 10670251
    [No Abstract]   [Full Text] [Related]  

  • 15. Cationic liposomal lipids: from gene carriers to cell signaling.
    Lonez C; Vandenbranden M; Ruysschaert JM
    Prog Lipid Res; 2008 Sep; 47(5):340-7. PubMed ID: 18424270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium neurotoxin fragments as potential targeting moieties for liposomal gene delivery to the CNS.
    Andreu A; Fairweather N; Miller AD
    Chembiochem; 2008 Jan; 9(2):219-31. PubMed ID: 18076008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
    Papadopoulos N; Kinzler KW; Vogelstein B
    Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
    Vorhies JS; Nemunaitis J
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):373-82. PubMed ID: 17338656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology.
    Suzuki R; Takizawa T; Negishi Y; Utoguchi N; Maruyama K
    Int J Pharm; 2008 Apr; 354(1-2):49-55. PubMed ID: 18082343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.